Treatment of advanced Non-small cell lung cancer
Advanced lung cancer, especially non-sq NSCLC, has been a great success in targeted therapy and immunotherapy, providing more options for clinical treatment and prolonging progression-free survival (PFS) and overall survival (OS ), Improving the patient’s quality of life (QoL).